Stock listing

GH Stock Price, News, Filings & Events — Guardant Health, Inc.

Selected listing: GH · BIVA · MXN · MX

This page tracks Guardant Health, Inc.'s GH:BIVA listing on BIVA in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GH:BIVA. GH:BIVA is the stock-level entry point for investors researching Guardant Health, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Guardant Health, Inc. is a publicly traded company listed under the ticker GH, operating in the American market. The company has a market capitalization of approximately $19.54 billion. Guardant Health specializes in advanced genomic testing for cancer, focusing on non-invasive blood tests to help guide treatment decisions.

GH:BIVAMXNMXUpdated August 28, 2026
Guardant Health, Inc. logo
Ticker
GH:BIVA
Asset type
Stock
Market cap
$21.67B
Sector
Health Technology
Industry
Medical Specialties
Exchange
BIVA
Currency
MXN

Guardant Health, Inc. GH:BIVA stock context

This page tracks Guardant Health, Inc.'s GH:BIVA listing on BIVA in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GH:BIVA. GH:BIVA is the stock-level entry point for investors researching Guardant Health, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Guardant Health, Inc. is a publicly traded company listed under the ticker GH, operating in the American market. The company has a market capitalization of approximately $19.54 billion. Guardant Health specializes in advanced genomic testing for cancer, focusing on non-invasive blood tests to help guide treatment decisions.

Latest news from Guardant Health, Inc.

All Guardant Health, Inc. news →

Guardant Health, Inc. earnings calls

Research Guardant Health, Inc.

Alternate listings